» Authors » Andrew Sharabi

Andrew Sharabi

Explore the profile of Andrew Sharabi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 1177
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Sahebjam S, Sharabi A, Lim M, Kesarwani P, Chinnaiyan P
J Neurooncol . 2017 Jun; 134(3):531-539. PMID: 28567588
Radiation therapy plays a central role in the management of glioblastoma. Although primarily thought of as modality to provide local tumor control through DNA damage, the capacity of ionizing radiation...
12.
Sharabi A, Kim S, Kato S, Sanders P, Patel S, Sanghvi P, et al.
Oncologist . 2017 May; 22(6):631-637. PMID: 28550027
Key Points: High-grade, large-cell neuroendocrine carcinoma of the cervix is an ultra-rare malignancy that carries a grim prognosis.Next-generation sequencing may reveal key mutations in genes amongst others. mutations target the...
13.
Kato S, Goodman A, Walavalkar V, Barkauskas D, Sharabi A, Kurzrock R
Clin Cancer Res . 2017 Mar; 23(15):4242-4250. PMID: 28351930
Checkpoint inhibitors demonstrate salutary anticancer effects, including long-term remissions. PD-L1 expression/amplification, high mutational burden, and mismatch repair deficiency correlate with response. We have, however, observed a subset of patients who...
14.
Green G, Carmona R, Zakeri K, Lee C, Borgan S, Marhoon Z, et al.
PLoS One . 2016 Jul; 11(7):e0156489. PMID: 27383192
As genetic information becomes more readily available, there is increasing demand from both patients and providers to develop personalized approaches to cancer care. Investigators are increasingly reporting numbers of studies...
15.
Lerner S, Bajorin D, Dinney C, Efstathiou J, Groshen S, Hahn N, et al.
Bladder Cancer . 2016 Jul; 2(2):165-202. PMID: 27376138
The NCI Bladder Cancer Task Force convened a Clinical Trials Planning Meeting (CTPM) Workshop focused on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer (NMIBC). Meeting attendees included a broad and...
16.
Robertson S, Quon H, Kiess A, Moore J, Yang W, Cheng Z, et al.
Med Phys . 2015 Jul; 42(7):4329-37. PMID: 26133630
Purpose: To develop a hypothesis-generating framework for automatic extraction of dose-outcome relationships from an in-house, analytic oncology database. Methods: Dose-volume histograms (DVH) and clinical outcomes have been routinely stored to...
17.
Pinkawa M, Schoth F, Bohmer D, Hatiboglu G, Sharabi A, Song D, et al.
Expert Rev Anticancer Ther . 2012 Dec; 13(1):75-88. PMID: 23259429
Definitive radiation therapy is a well-recognized curative treatment option for localized prostate cancer. A suitable technique, dose, target volume and the option of a combination with androgen deprivation therapy need...
18.
Lee S, Hong B, Sharabi A, Huang X, Chen S
Stem Cells . 2009 Jun; 27(7):1604-15. PMID: 19544467
Stem cells are normally maintained in a quiescent state and proliferate only under certain conditions; however, little is known about the biological stimuli that initiate the proliferation and differentiation of...
19.
Koshikawa N, Minegishi T, Sharabi A, Quaranta V, Seiki M
J Biol Chem . 2004 Nov; 280(1):88-93. PMID: 15525652
Processing of the laminin-5 (Ln-5) gamma 2 chain by membrane-type-1 matrix metalloproteinases (MT1-MMP) promotes migration and invasion of epithelial and tumor cells. We previously demonstrated that MT1-MMP cleaves the rat...
20.
Bilban M, Ghaffari-Tabrizi N, Hintermann E, Bauer S, Molzer S, Zoratti C, et al.
J Cell Sci . 2004 Mar; 117(Pt 8):1319-28. PMID: 15020672
Trophoblast invasion of the uterine extracellular matrix, a critical process of human implantation and essential for fetal development, is a striking example of controlled invasiveness. To identify molecules that regulate...